Brief: Lineage Cell Therapeutics Announces Pricing Of Up To $66 Million Registered Direct Offering
20/11/2024 13:04
Nov 20 (Reuters) - Lineage Cell Therapeutics Inc
LCTX.A :
* LINEAGE CELL THERAPEUTICS ANNOUNCES PRICING OF UP TO $66
MILLION
REGISTERED DIRECT OFFERING
* LINEAGE CELL THERAPEUTICS INC - OFFERING INCLUDES $30
MILLION
UPFRONT, $36 MILLION IN WARRANTS
Source text: ID:nBw42xRZPa
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million